• Something wrong with this record ?

People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe - data from Euro-guidelines in Central and Eastern Europe Network

T. Balayan, C. Oprea, O. Yurin, D. Jevtovic, J. Begovac, B. Lakatos, D. Sedlacek, I. Karpov, A. Horban, JD. Kowalska, Euro-guidelines in Central and Eastern Europe Network Group,

. 2019 ; 51 (4) : 277-286. [pub] 20190221

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19044982

BACKGROUND/OBJECTIVES: Inadequate HIV care for hard-to-reach populations may result in failing the UNAIDS 90-90-90 goal. Therefore, we aimed to review the HIV continuum of care and hard-to-reach populations for each step of the continuum in Central, Eastern and South Eastern Europe. METHODS: Euro-guidelines in Central and Eastern Europe (ECEE) Network Group were created in February 2016. The aim of the network was to review the standards of HIV care in the countries of the region. Information about each stage of HIV continuum of care and hard-to-reach populations for each stage was collected through on-line surveys. Respondents were ECEE members chosen based on their expertise and involvement in national HIV care. Data sources (year 2016) used by respondents included HIV Clinics electronic databases, Institutes of Public Health, Centres for AIDS Prevention, and HIV Programme Reviews. RESULTS: The percentage of people living with HIV (PLHIV) linked to HIV care after HIV diagnosis was ranged between 80% and 96% in Central Europe, 51% and 92% in Eastern Europe and 80% and 100% in South-Eastern Europe. The percentage of PLHIV who are on ART was ranged from 80% to 93% in Central Europe, 18% to 92% in Eastern Europe and 80% to 100% in South-Eastern Europe. The percentage of people virologically suppressed while on ART was reported as 70-95%, 12-95% and 62-97% in Central, Eastern, and South Eastern Europe, respectively. All three regions reported people who inject drugs (PWID) as hard-to-reach population across all HIV continuum stages. Migrants were the second most reported hard-to-reach population. The proportion of late presenters among newly diagnosed ranged between 20% and 55%, 40% and 55% and 48% and 60% in Central, Eastern and South Eastern Europe, respectively. Four countries reported ARVs' delivery delays resulting in treatment interruptions in 2016: two (25%) in South-Eastern, one (20%) in Central and 1 (16.7%) in Eastern Europe. CONCLUSION: Irrespective of the diversity in national HIV epidemics, countries from all three regions reported PWIDs as hard-to-reach population across all HIV continuum stages. Some countries are close to the UNAIDS 2020 goals, others need to strive for progress. However, differences in data sources and variations in definitions limit the utility of continuum of care as a comparative tool.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19044982
003      
CZ-PrNML
005      
20200114144547.0
007      
ta
008      
200109s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/23744235.2019.1565415 $2 doi
035    __
$a (PubMed)30786803
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Balayan, Tatevik $u a National Center for Disease Control and Prevention , Yerevan , Armenia.
245    10
$a People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe - data from Euro-guidelines in Central and Eastern Europe Network / $c T. Balayan, C. Oprea, O. Yurin, D. Jevtovic, J. Begovac, B. Lakatos, D. Sedlacek, I. Karpov, A. Horban, JD. Kowalska, Euro-guidelines in Central and Eastern Europe Network Group,
520    9_
$a BACKGROUND/OBJECTIVES: Inadequate HIV care for hard-to-reach populations may result in failing the UNAIDS 90-90-90 goal. Therefore, we aimed to review the HIV continuum of care and hard-to-reach populations for each step of the continuum in Central, Eastern and South Eastern Europe. METHODS: Euro-guidelines in Central and Eastern Europe (ECEE) Network Group were created in February 2016. The aim of the network was to review the standards of HIV care in the countries of the region. Information about each stage of HIV continuum of care and hard-to-reach populations for each stage was collected through on-line surveys. Respondents were ECEE members chosen based on their expertise and involvement in national HIV care. Data sources (year 2016) used by respondents included HIV Clinics electronic databases, Institutes of Public Health, Centres for AIDS Prevention, and HIV Programme Reviews. RESULTS: The percentage of people living with HIV (PLHIV) linked to HIV care after HIV diagnosis was ranged between 80% and 96% in Central Europe, 51% and 92% in Eastern Europe and 80% and 100% in South-Eastern Europe. The percentage of PLHIV who are on ART was ranged from 80% to 93% in Central Europe, 18% to 92% in Eastern Europe and 80% to 100% in South-Eastern Europe. The percentage of people virologically suppressed while on ART was reported as 70-95%, 12-95% and 62-97% in Central, Eastern, and South Eastern Europe, respectively. All three regions reported people who inject drugs (PWID) as hard-to-reach population across all HIV continuum stages. Migrants were the second most reported hard-to-reach population. The proportion of late presenters among newly diagnosed ranged between 20% and 55%, 40% and 55% and 48% and 60% in Central, Eastern and South Eastern Europe, respectively. Four countries reported ARVs' delivery delays resulting in treatment interruptions in 2016: two (25%) in South-Eastern, one (20%) in Central and 1 (16.7%) in Eastern Europe. CONCLUSION: Irrespective of the diversity in national HIV epidemics, countries from all three regions reported PWIDs as hard-to-reach population across all HIV continuum stages. Some countries are close to the UNAIDS 2020 goals, others need to strive for progress. However, differences in data sources and variations in definitions limit the utility of continuum of care as a comparative tool.
650    _2
$a AIDS $x farmakoterapie $x epidemiologie $7 D000163
650    _2
$a ambulantní zařízení $x statistika a číselné údaje $7 D000554
650    _2
$a vysoce aktivní antiretrovirová terapie $7 D023241
650    _2
$a kontinuita péče o pacienty $x organizace a řízení $x statistika a číselné údaje $7 D003266
650    _2
$a uživatelé drog $x statistika a číselné údaje $7 D055030
650    _2
$a HIV infekce $x farmakoterapie $x epidemiologie $7 D015658
650    _2
$a lidé $7 D006801
650    _2
$a intravenózní abúzus drog $x virologie $7 D015819
650    _2
$a průzkumy a dotazníky $7 D011795
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Oprea, Cristiana $u b Victor Babes Clinical Hospital for Infectious Diseases, Carol Davila University of Medicine and Pharmacy , Bucharest , Romania.
700    1_
$a Yurin, Oleg $u c Central Research Institute of Epidemiology, Federal AIDS Centre , Moscow , Russian Federation.
700    1_
$a Jevtovic, Djorde $u d Belgrade University Medical School, Infectious Diseases Hospital , Belgrade Serbia.
700    1_
$a Begovac, Josip $u e University of Zagreb School of Medicine, University Hospital of Infectious Diseases , Zagreb , Croatia.
700    1_
$a Lakatos, Botond $u f Saint Laszlo Hospital National Center of HIV, Semmelweis University Faculty of Infectious Diseases , Budapest , Hungary.
700    1_
$a Sedlacek, Dalibor $u g Charles University Hospital in Pilsen , Pilsen , Czech Republic.
700    1_
$a Karpov, Igor $u h Belarus State Medical University , Minsk , Belarus.
700    1_
$a Horban, Andrzej $u i Hospital for Infectious Diseases Medical University of Warsaw , Warsaw , Poland.
700    1_
$a Kowalska, Justyna D $u i Hospital for Infectious Diseases Medical University of Warsaw , Warsaw , Poland.
710    2_
$a Euro-guidelines in Central and Eastern Europe Network Group
773    0_
$w MED00191578 $t Infectious diseases (London, England) $x 2374-4243 $g Roč. 51, č. 4 (2019), s. 277-286
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30786803 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200114144920 $b ABA008
999    __
$a ok $b bmc $g 1483251 $s 1083655
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 51 $c 4 $d 277-286 $e 20190221 $i 2374-4243 $m Infectious diseases $n Infect Dis (Lond) $x MED00191578
LZP    __
$a Pubmed-20200109

Find record

Citation metrics

Archiving options